Ridgefield, Connecticut, United States
Responsible for building short, medium, and long term financial plans; financial modeling, and analyzing business performance.
• Supported the Operations group with $1.5B Value of Production to analyze the financial performance of the Medication & Procedural Solutions (MPS) business unit and 20+ manufacturing plants versus Budget/Projection and drive Gross Profit (GP) improvement through cost reductions. -Reviewed monthly plant performance to understand productivity drivers and its impact on the rest of year. -Partnered with plant managers, engineers & cost improvement specialists to identify & support cost savings programs and calculate/report the savings from those programs. -Worked with plant controllers and plant managers to develop the annual budget & understand drivers of change versus prior year. Investigated & identified opportunities for improvement to close budget gaps and meet the business unit’s goals for cost reduction and GP growth. -Partnered with the Operations VP and Directors of Manufacturing to manage $200M of capital spending across 20 plants to improve GP through cost improvement initiatives and critical capacity expansion. -Built financial models to support new capital spending requests by demonstrating P&L cost savings and calculating NPV, MIRR & payback period for projects. -Core member in the Finance Transformation project which streamlined, standardized & automated BD’s management & reporting of capital spending across multiple business units. -Supported post-acquisition integration efforts to absorb 7 additional manufacturing sites from the purchase of CareFusion. -Managed the business unit’s month-end close and consolidated reporting of manufacturing variances for US plants and division.
•Supported Financial Planning & Analysis process, analyzing financial performance for BD and its reporting segments on a monthly, quarterly and year-to-date basis, including; -Reviewed monthly/quarterly P&L results vs. prior year and vs. projection with BU leaders to understand drivers of company performance. -Prepared Quarterly Earnings Book for CFO & VP of Finance to summarize company & segment performance, highlight drivers of growth and earnings “story” relative to Wall Street Guidance. Also prepared presentations for Board of Directors & Management Committee meetings and other ad hoc presentations as needed. -Developed Free Cash Flow reporting model to measure company & segment performance beyond earnings per share and participated in quarterly Working Capital Efficiency reviews to improve Free Cash Flow. -Developed BU and Segment growth profiles for the annual budget and 3 year strategic planning process in order to reach the desired company-wide growth profile for the coming fiscal year’s external guidance. -Coordinated communications on the Budget, Projection, and 3 year strategic plan to worldwide finance teams.
•Performed buy-side and sell-side financial due diligence to identity valuation issues for clients before deal-closing for pending acquisitions, including; -Revenue analysis by customers, products, and/or geographic areas to distinguish sustainable core business growth from non-recurring items. -P&L trending to identify one-time expenses and revenue recorded under US GAAP but not contributing to the quality of earnings from core business. -Balance sheet analysis to understand a business’ working capital needs over time. Also examined A/R and inventory for aged balances that may be at-risk and performed benchmark analysis for early indication of future reserve requirements. -Participated in management meetings with top level target and client management to discuss business performance and understand potential non-recurring income or expense items identified during due diligence.